Endovascular Repair of Abdominal Aortic Aneurysm in Patients Physically Ineligible for Open Repair: Very Long-term Follow-up in the EVAR-2 Randomized Controlled Trial.
View / Open Files
Authors
Patel, Rajesh
Powell, Janet T
Greenhalgh, Roger M
EVAR Trial Investigators,
Publication Date
2017-11Journal Title
Annals of surgery
ISSN
0003-4932
Volume
266
Issue
5
Pages
713-719
Language
eng
Type
Article
This Version
AM
Physical Medium
Print
Metadata
Show full item recordCitation
Sweeting, M., Patel, R., Powell, J. T., Greenhalgh, R. M., & EVAR Trial Investigators,. (2017). Endovascular Repair of Abdominal Aortic Aneurysm in Patients Physically Ineligible for Open Repair: Very Long-term Follow-up in the EVAR-2 Randomized Controlled Trial.. Annals of surgery, 266 (5), 713-719. https://doi.org/10.1097/sla.0000000000002392
Abstract
OBJECTIVE: The aim of the study was to compare long-term total and aneurysm-related mortality in physically frail patients with abdominal aortic aneurysm (AAA) randomized to either early endovascular aneurysm repair (EVAR) or no-intervention. SUMMARY BACKGROUND DATA: EVAR-2 remains the sole randomized trial to identify whether EVAR reduces mortality in patients physically ineligible for open repair. METHODS: Between September 1999 and August 2004, 404 patients from 33 centers in the United Kingdom aged ≥60 years with AAA >5.5 cm in diameter were randomized 1:1 using computer-generated sequences of randomly permuted blocks stratified by center to receive either EVAR (197) or no-intervention (207). The primary analysis compared total and aneurysm-related deaths in groups until June 30, 2015 (mean, 12.0 yrs; maximum 14.1 yrs). RESULTS: Mean follow-up until death or censoring was 4.2 years. There were 187 deaths (22.6 per 100 person-yrs) in the EVAR group and 194 (22.1 per 100 person-yrs) in the no-intervention group. By 12 years of follow-up the estimated survival was 5.3% [95% confidence interval (CI), 2.6-9.2] in the EVAR group and 8.5% (95% CI, 5.2-12.9) in the no-intervention group; there was no significant difference in life expectancy between the groups (both 4.2 yrs; P = 0.97). However, overall aneurysm-related mortality was significantly lower in the EVAR group [3.3 deaths per 100 person-yrs compared with 6.5 deaths per 100 person-yrs in the no-intervention group, adjusted hazard ratio 0.55 (95% CI, 0.34-0.91; P = 0.019)]. Patients surviving beyond 8 years were younger, with higher body mass index, estimated glomerular filtration rate, and forced expiratory volume in 1 second. CONCLUSIONS: EVAR does not increase overall life expectancy in patients ineligible for open repair, but can reduce aneurysm-related mortality.
Keywords
EVAR Trial Investigators, Humans, Aortic Aneurysm, Abdominal, Treatment Outcome, Life Expectancy, Follow-Up Studies, Aged, Aged, 80 and over, Female, Male, Endovascular Procedures, United Kingdom
Sponsorship
MRC (MR/L003120/1)
British Heart Foundation (RG/08/014/24067)
Identifiers
External DOI: https://doi.org/10.1097/sla.0000000000002392
This record's URL: https://www.repository.cam.ac.uk/handle/1810/269984
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved